Stockreport

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

CARL ZEISS MEDI UNSP/ADR  (CZMWY) 
NASDAQ:AMEX Investor Relations: zeiss.com/meditec-ag/investor-relations.html
PDF The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmat [Read more]